Federal Preemption Defense Under Fire In Draft House Bills

A one-sentence provision tucked into draft legislation circulating in a House subcommittee seeks to weaken device and drug manufacturers' ability to claim FDA approval as a defense in state product liability lawsuits

More from Archive

More from Medtech Insight